Inventurus Knowledge Solutions
- Market Cap
- ₹28,152 Cr
- P/E
- 35.17
Key Fundamentals
SmallcapIT - ServicesInformation TechnologyPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 31.50%
- Debt to Equity
- 1.78
- EPS (TTM)
- ₹46.65
- Book Value
- ₹194.67
- Market Cap
- ₹28,152 Cr
- P/E (TTM)
- 35.17
- P/B
- 8.43
- ROE
- 31.40%
- Dividend Yield
- 0.00%
- EBITDA
- ₹1,109 Cr
- 52W High
- ₹1,970.00
- 52W Low
- ₹1,262.00
- Day Range
- ₹1,590.90 – ₹1,648.00
- Volume
- 95,054
Peer Comparison
Information Technology › IT - Services › IT Enabled Services
| 4,082.50 | 28.12 | 43,310 | 6.12 | 0.49% | 21.50% | 26.70% | 11,626 | 1,542 | |
| 727.90 | 52.52 | 29,557 | 7.71 | 1.78% | 16.30% | 20.90% | 6,301 | 563 | |
| 1,640.80 | 35.17 | 28,152 | 8.43 | 0.00% | 31.40% | 31.50% | 4,159 | 796 | |
| 4,095.50 | 64.69 | 24,347 | 11.57 | 0.07% | 32.80% | 37.50% | 3,722 | 366 | |
| 1,599.40 | 45.31 | 23,015 | 5.33 | 0.00% | 13.80% | 16.80% | 2,973 | 497 | |
| 45.25 | 20.66 | 21,183 | 2.07 | 0.33% | 10.60% | 13.40% | 7,991 | 1,027 | |
| 896.40 | 64.91 | 15,920 | 11.24 | 0.11% | 25.70% | 21.60% | 7,005 | 244 | |
| Median 7 companies | 1,599.40 | 45.31 | 24,347 | 7.71 | 0.11% | 21.50% | 21.60% | 6,301 | 563 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 81
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 33
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 82
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 51
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 62
- Good
- Trend strength, vol-adjusted 12% weight
- Ownership
- 53
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is expected to give good quarter
- Company has delivered good profit growth of 34.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.1%
Weaknesses
3- Stock is trading at 8.43 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 5 | 3 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 9 | 0 | 1 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 44.15
- Neutral
- MACD (12,26,9)
- −28.16
- Bearish
- SMA (50)
- 1,723.36
- Bearish
- SMA (200)
- 1,660.01
- Bearish
As of
Analyst Rating
7 of 8 analysts rate Buy, 1 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 5Y | +42.01% |
|---|---|
| 3Y | +45.78% |
| 1Y | +19.89% |
| TTM | +43.31% |
Net profit
| 5Y | +34.34% |
|---|---|
| 3Y | +33.27% |
| 1Y | +48.56% |
| TTM | +30.28% |
Operating cash flow
| 5Y | +30.96% |
|---|---|
| 3Y | +32.77% |
| 1Y | +111.95% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −3.13 pp |
|---|---|
| 3Y | −4.08 pp |
| 1Y | +5.00 pp |
| TTM | −0.13 pp |
Revenue by year
| Mar 2020 | ₹529 Cr |
|---|---|
| Mar 2021 | ₹553 Cr |
| Mar 2022 | ₹764 Cr |
| Mar 2023 | ₹1,031 Cr |
| Mar 2024 | ₹1,818 Cr |
| Mar 2025 | ₹2,664 Cr |
| Mar 2026 | ₹3,194 Cr |
Net profit by year
| Mar 2020 | ₹137 Cr |
|---|---|
| Mar 2021 | ₹165 Cr |
| Mar 2022 | ₹233 Cr |
| Mar 2023 | ₹305 Cr |
| Mar 2024 | ₹370 Cr |
| Mar 2025 | ₹486 Cr |
| Mar 2026 | ₹722 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Inventurus Knowledge Solutions Ltd trades at ₹1,606 as of 2026-11-19 with a market capitalisation of ₹27,555 crore and a trailing PE of 34.43x. The company has demonstrated strong revenue and profit compounding over five years (sales CAGR 42%, profit CAGR 34%) alongside robust return ratios (ROE 25.77%, ROCE 29.57%), but trades at a premium valuation of 8.25x book value and pays no dividend.
- Compounded sales growth of 42% over the last 5 years and 46% over the last 3 years indicates a sustained, accelerating revenue trajectory
- Compounded profit growth of 34% over 5 years and 30% over 3 years demonstrates strong earnings scalability alongside top-line expansion
- TTM sales growth of 43% and TTM profit growth of 31% show that momentum remains intact in the most recent period
- ROE of 25.77% and a 3-year average ROE of 33% reflect efficient capital allocation and high-quality earnings generation
- ROCE of 29.57% suggests the business generates healthy returns on total capital employed, well above typical cost-of-capital benchmarks
- Debt-to-equity ratio of just 0.27 indicates a conservatively financed balance sheet with limited leverage risk
- The company is expected to deliver a good upcoming quarter, suggesting near-term earnings momentum may continue
- At a PE of 34.43x, the stock is priced for continued high growth — any deceleration in the 30-40% earnings trajectory could trigger a de-rating
- Zero dividend yield despite repeated profitability raises questions about capital return policy and shareholder alignment
- The possibility that the company may be capitalising interest costs could mean reported profits overstate true operating earnings
- 1-year stock CAGR of just 1% suggests the market has not rewarded the underlying earnings growth recently, pointing to possible valuation fatigue
- Last-year ROE of 31% has declined from the 3-year average of 33% and 5-year average of 36%, signalling a gradual compression in return efficiency
- A market cap of ₹27,555 crore paired with a TTM EPS of ₹46.65 implies the stock needs to sustain above-30% profit growth for several years to justify current pricing
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: IKS delivered strong Q2FY27 results with 104% revenue growth and 18% profit growth, largely powered by the TruBridge acquisition. Corporate restructuring via the Turbo Health merger and acquisition signals ongoing integration of its US RCM business. No material headwinds are visible in recent news. The key forward question is whether the company can sustain growth and margin trajectory as acquisition-driven tailwinds normalize.
- Q2 profit up 18% YoY Nov 5
Consolidated net profit rose 18% YoY to ₹2,133.71 million in Q2FY27. Revenue surged 104% to ₹15,924.78 million, driven by the TruBridge acquisition.
- Turbo Health merger completed Nov 20
Merger of Turbo Health Holdings with IKS Inc completed on November 20, 2026, with no cash consideration or share issuance. Consolidation aims to reduce compliance overheads for the newly acquired RCM entity.
- Turbo Health acquired for $500K Nov 10
US subsidiary acquired 100% of Turbo Health Holdings for $500,000. The target is a newly formed entity holding transferred client contracts.
Quarterly Results
₹ Cr| Particulars | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 567 | 620 | 640 | 643 | 657 | 724 | 740 | 781 | 815 | 858 | 894 | 1,592 |
| Expenses | 405 | 494 | 467 | 454 | 476 | 498 | 502 | 511 | 536 | 563 | 604 | 1,151 |
| Operating Profit | 162 | 126 | 173 | 189 | 181 | 226 | 238 | 270 | 279 | 295 | 290 | 442 |
| OPM % | 29% | 20% | 27% | 29% | 28% | 31% | 32% | 35% | 34% | 34% | 32% | 28% |
| Other Income | 6 | 15 | 4 | 5 | 27 | 3 | 3 | 4 | 6 | 5 | 6 | 23.38 |
| Interest | 26 | 32 | 26 | 22 | 21 | 21 | 18 | 16 | 23 | 13 | 10 | 102 |
| Depreciation | 19 | 27 | 28 | 28 | 28 | 28 | 28 | 30 | 32 | 34 | 34 | 89.79 |
| PBT | 124 | 81 | 122 | 144 | 160 | 180 | 195 | 229 | 229 | 253 | 251 | 273 |
| Tax % | 18% | 21% | 22% | 21% | 19% | 18% | 22% | 21% | 20% | 19% | 23% | 22% |
| Net Profit | 102 | 64 | 95 | 113 | 130 | 148 | 152 | 181 | 183 | 206 | 194 | 213 |
| EPS (₹) | 5.92 | 3.71 | 5.57 | 6.59 | 7.56 | 8.61 | 8.83 | 10.53 | 10.68 | 12.00 | 11.29 | 12.68 |
| YoY Sales growth | — | — | — | — | 16 | 17 | 16 | 22 | 24 | 18 | 21 | 104 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 (S) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 161 | 203 | 529 | 553 | 764 | 1,031 | 1,818 | 2,664 | 3,194 | 4,159 |
| Expenses | 139 | 149 | 367 | 348 | 466 | 639 | 1,297 | 1,893 | 2,110 | 2,854 |
| Operating Profit | 22 | 54 | 162 | 205 | 298 | 392 | 521 | 771 | 1,084 | 1,305 |
| OPM % | 14% | 27% | 31% | 37% | 39% | 38% | 29% | 29% | 34% | 31% |
| Other Income | 0 | 0 | 31 | 16 | 1 | −2 | 40 | 39 | 17 | 40 |
| Interest | 8 | 8 | 7 | 8 | 7 | 6 | 61 | 89.77 | 70.25 | 148 |
| Depreciation | 5 | 10 | 40 | 30 | 23 | 25 | 59 | 113 | 124 | 190 |
| PBT | 8 | 36 | 145 | 183 | 269 | 359 | 442 | 606 | 905 | 1,006 |
| Tax % | 0% | 0% | 5% | 9% | 13% | 15% | 16% | 20% | 20% | — |
| Net Profit | 8 | 36 | 137 | 165 | 233 | 305 | 370 | 486 | 722 | 796 |
| EPS (₹) | 0.48 | 2.11 | 8.01 | 9.64 | 13.58 | 17.79 | 21.59 | 28.33 | 42.03 | 46.65 |
| Div. Payout % | 0% | 0% | 0% | 12% | 393% | 55% | 0% | 0% | 0% | — |
| Sales growth | — | 27 | — | 4 | 38 | 35 | 76 | 47 | 20 | 43 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 (S) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | −40 | −2 | 275 | 449 | 630 | 812 | 1,141 | 1,773 | 2,783 | 3,323 |
| Borrowings | 74 | 79 | 0 | 76 | 65 | 52 | 1,311 | 856 | 753 | 5,959 |
| Other Liabilities | 58 | 66 | 151 | 53 | 75 | 107 | 411 | 274 | 605 | 1,695 |
| Total Liabilities | 100 | 151 | 434 | 586 | 788 | 988 | 2,880 | 2,919 | 4,158 | 10,994 |
| Fixed Assets | 16 | 32 | 36 | 87 | 76 | 59 | 1,833 | 1,790 | 1,942 | 7,823 |
| CWIP | 14 | 26 | 0 | 0 | 0 | 0 | 3 | 13 | 6 | 0 |
| Investments | 4 | 4 | 1 | 14 | 16 | 32 | 195 | 114 | 377 | 157 |
| Other Assets | 66 | 88 | 397 | 485 | 695 | 898 | 849 | 1,003 | 1,832 | 3,013 |
| Total Assets | 100 | 151 | 434 | 586 | 788 | 988 | 2,880 | 2,919 | 4,158 | 10,994 |
Cash Flow
₹ Cr| Particulars | Mar 2015 (S) | Mar 2016 (S) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | 16 | 52 | 163 | 175 | 233 | 288 | 210 | 318 | 674 |
| Investing | −21 | −38 | −79 | −167 | −82 | −158 | −1,137 | 241 | −222 |
| Financing | 5 | −2 | −41 | −37 | −59 | −152 | 780 | −389 | −412 |
| Net Cash Flow | 0 | 12 | 43 | −28 | 92 | −22 | −147 | 170 | 39 |
| Free Cash Flow | −5 | 13 | 152 | 168 | 222 | 280 | 177 | 276 | 614 |
| CFO/EBITDA | 75 | 109 | 118 | 100 | 93 | 93 | 58 | 56 | 80 |
Ratios
| Particulars | Mar 2015 (S) | Mar 2016 (S) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 130 | 101 | 51 | 49 | 46 | 57 | 73 | 73 | 65 |
| Cash Conversion Cycle | 130 | 101 | 51 | 49 | 46 | 57 | 73 | 73 | 65 |
| Working Capital Days | −80 | −38 | 20 | 41 | 15 | 21 | −75 | 10 | −31 |
| ROCE % | — | 70% | — | 47% | 47% | 50% | 30% | 27% | 32% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Inventurus Knowledge Solutions insights
67 extracted metrics across FY16–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript
- Q4 FY26 concall · Apr 2026Transcript PPT Recording
- Concall · Apr 2026PPT
- 22 Jun 2026
- General announcements 19 Nov 2026
Frequently Asked Questions about Inventurus Knowledge Solutions
What does Inventurus Knowledge Solutions Ltd do?
Where is Inventurus Knowledge Solutions Ltd (IKS) listed?
Which sector does Inventurus Knowledge Solutions Ltd belong to?
What is the market capitalisation of Inventurus Knowledge Solutions Ltd?
What is the PE ratio of Inventurus Knowledge Solutions Ltd?
What is the 52-week high and low of Inventurus Knowledge Solutions Ltd?
What is the Return on Equity (ROE) of Inventurus Knowledge Solutions Ltd?
Company Information
Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/IKS.md for Inventurus Knowledge Solutions Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.